Structure via PubChem · Public domain (PubChem)
terizidone
Sign in to saveTerizidone is a drug used in the treatment of tuberculosis. Terizidone is mainly used in multi-drug-resistant tuberculosis (MDR-TB) in conjunction with other second-line drugs. It is a derivative of cycloserine with bacteriostatic activity.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 470602455
- Drug.IUPAC_name
- 4,4'-{1,4-phenylenebis[(E)methylylidene(E)azanylylidene]}bis(1,2-oxazolidin-3-one)
- Drug.image
- Terizidone.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 275
- Drug.tradename
- Terivalidin
- Drug.ATC_prefix
- J04
- Drug.ATC_suffix
- AK03
- Drug.CAS_number
- 25683-71-0
- Drug.PubChem
- 65720
- Drug.ChemSpiderID
- 59144
- Drug.UNII
- 1199LEX5N8
- Drug.KEGG
- D07247
- Drug.C
- 14
- Drug.H
- 14
- Drug.N
- 4
via Wikipedia infobox
Chemical data
- Formula
- C14H14N4O4
- Molecular weight
- 302.29 g/mol
- IUPAC name
- 4-[[4-[(3-oxo-1,2-oxazolidin-4-yl)iminomethyl]phenyl]methylideneamino]-1,2-oxazolidin-3-one
- SMILES
- C1C(C(=O)NO1)N=CC2=CC=C(C=C2)C=NC3CONC3=O
- InChIKey
- ODKYYBOHSVLGNU-UHFFFAOYSA-N
- XLogP
- -0.2
- Polar surface area
- 101 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 302.101504928
Show 3 more facts
- canonical SMILES
- c1c(ccc(c1)/C=N/C2C(=O)NOC2)/C=N/C3C(=O)NOC3
- chemical formula
- C₁₄H₁₄N₄O₄
- Commons category
- Terizidone
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
1 sectionsContents
- References
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 470602455 | IUPAC_name = 4,4'-{1,4-phenylenebis[(E)methylylidene(E)azanylylidene]}bis(1,2-oxazolidin-3-one) | image = Terizidone.svg | image_class = skin-invert-image | width = 275 | alt =
| tradename = Terivalidin | Drugs.com = | pregnancy_AU = | pregnancy_category = | routes_of_administration = | ATC_prefix = J04 | ATC_suffix = AK03
Excerpted from Wikipedia’s “terizidone” article, available under the CC BY-SA 4.0 licence.